Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 293

1.

High-Carbohydrate vs High-Fat Nutrition for Burn Patients.

Shields BA, VanFosson CA, Pruskowski KA, Gurney JM, Rizzo JA, Cancio LC.

Nutr Clin Pract. 2019 Aug 22. doi: 10.1002/ncp.10396. [Epub ahead of print] Review.

PMID:
31441112
2.

Clusters provide a better holistic view of type 2 diabetes than simple clinical features - Authors' reply.

Dennis JM, Shields BM, Henley WE, Jones AG, Hattersley AT.

Lancet Diabetes Endocrinol. 2019 Sep;7(9):669. doi: 10.1016/S2213-8587(19)30250-5. No abstract available.

PMID:
31439274
3.

Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth: A Systematic Review and Meta-analysis.

Consortium on Thyroid and Pregnancy—Study Group on Preterm Birth, Korevaar TIM, Derakhshan A, Taylor PN, Meima M, Chen L, Bliddal S, Carty DM, Meems M, Vaidya B, Shields B, Ghafoor F, Popova PV, Mosso L, Oken E, Suvanto E, Hisada A, Yoshinaga J, Brown SJ, Bassols J, Auvinen J, Bramer WM, López-Bermejo A, Dayan C, Boucai L, Vafeiadi M, Grineva EN, Tkachuck AS, Pop VJM, Vrijkotte TG, Guxens M, Chatzi L, Sunyer J, Jiménez-Zabala A, Riaño I, Murcia M, Lu X, Mukhtar S, Delles C, Feldt-Rasmussen U, Nelson SM, Alexander EK, Chaker L, Männistö T, Walsh JP, Pearce EN, Steegers EAP, Peeters RP.

JAMA. 2019 Aug 20;322(7):632-641. doi: 10.1001/jama.2019.10931.

PMID:
31429897
4.

The Interplay of Nutrition, Physical Activity, Severity of Illness, and Mortality in Critically Ill Burn Patients: Is There a Connection?

Shields BA, Carpenter JN, Bustillos BD, Jordan AN, Cunningham KB, Vega SJ, Aden JK, Rowan MP, Rizzo JA, Dewey WS, Gurney JM, Ainsworth CR, Cancio LC.

J Burn Care Res. 2019 Jul 11. pii: irz126. doi: 10.1093/jbcr/irz126. [Epub ahead of print]

PMID:
31298707
5.

Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data.

Dennis JM, Shields BM, Henley WE, Jones AG, Hattersley AT.

Lancet Diabetes Endocrinol. 2019 Jun;7(6):442-451. doi: 10.1016/S2213-8587(19)30087-7. Epub 2019 Apr 29.

6.

Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors.

Warrington NM, Beaumont RN, Horikoshi M, Day FR, Helgeland Ø, Laurin C, Bacelis J, Peng S, Hao K, Feenstra B, Wood AR, Mahajan A, Tyrrell J, Robertson NR, Rayner NW, Qiao Z, Moen GH, Vaudel M, Marsit CJ, Chen J, Nodzenski M, Schnurr TM, Zafarmand MH, Bradfield JP, Grarup N, Kooijman MN, Li-Gao R, Geller F, Ahluwalia TS, Paternoster L, Rueedi R, Huikari V, Hottenga JJ, Lyytikäinen LP, Cavadino A, Metrustry S, Cousminer DL, Wu Y, Thiering E, Wang CA, Have CT, Vilor-Tejedor N, Joshi PK, Painter JN, Ntalla I, Myhre R, Pitkänen N, van Leeuwen EM, Joro R, Lagou V, Richmond RC, Espinosa A, Barton SJ, Inskip HM, Holloway JW, Santa-Marina L, Estivill X, Ang W, Marsh JA, Reichetzeder C, Marullo L, Hocher B, Lunetta KL, Murabito JM, Relton CL, Kogevinas M, Chatzi L, Allard C, Bouchard L, Hivert MF, Zhang G, Muglia LJ, Heikkinen J; EGG Consortium, Morgen CS, van Kampen AHC, van Schaik BDC, Mentch FD, Langenberg C, Luan J, Scott RA, Zhao JH, Hemani G, Ring SM, Bennett AJ, Gaulton KJ, Fernandez-Tajes J, van Zuydam NR, Medina-Gomez C, de Haan HG, Rosendaal FR, Kutalik Z, Marques-Vidal P, Das S, Willemsen G, Mbarek H, Müller-Nurasyid M, Standl M, Appel EVR, Fonvig CE, Trier C, van Beijsterveldt CEM, Murcia M, Bustamante M, Bonas-Guarch S, Hougaard DM, Mercader JM, Linneberg A, Schraut KE, Lind PA, Medland SE, Shields BM, Knight BA, Chai JF, Panoutsopoulou K, Bartels M, Sánchez F, Stokholm J, Torrents D, Vinding RK, Willems SM, Atalay M, Chawes BL, Kovacs P, Prokopenko I, Tuke MA, Yaghootkar H, Ruth KS, Jones SE, Loh PR, Murray A, Weedon MN, Tönjes A, Stumvoll M, Michaelsen KF, Eloranta AM, Lakka TA, van Duijn CM, Kiess W, Körner A, Niinikoski H, Pahkala K, Raitakari OT, Jacobsson B, Zeggini E, Dedoussis GV, Teo YY, Saw SM, Montgomery GW, Campbell H, Wilson JF, Vrijkotte TGM, Vrijheid M, de Geus EJCN, Hayes MG, Kadarmideen HN, Holm JC, Beilin LJ, Pennell CE, Heinrich J, Adair LS, Borja JB, Mohlke KL, Eriksson JG, Widén EE, Hattersley AT, Spector TD, Kähönen M, Viikari JS, Lehtimäki T, Boomsma DI, Sebert S, Vollenweider P, Sørensen TIA, Bisgaard H, Bønnelykke K, Murray JC, Melbye M, Nohr EA, Mook-Kanamori DO, Rivadeneira F, Hofman A, Felix JF, Jaddoe VWV, Hansen T, Pisinger C, Vaag AA, Pedersen O, Uitterlinden AG, Järvelin MR, Power C, Hyppönen E, Scholtens DM, Lowe WL Jr, Davey Smith G, Timpson NJ, Morris AP, Wareham NJ, Hakonarson H, Grant SFA, Frayling TM, Lawlor DA, Njølstad PR, Johansson S, Ong KK, McCarthy MI, Perry JRB, Evans DM, Freathy RM.

Nat Genet. 2019 May;51(5):804-814. doi: 10.1038/s41588-019-0403-1. Epub 2019 May 1.

PMID:
31043758
7.

What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study.

McGovern AP, Dennis JM, Shields BM, Hattersley AT, Pearson ER, Jones AG; MASTERMIND Consortium.

BMC Med. 2019 Apr 12;17(1):79. doi: 10.1186/s12916-019-1307-8.

8.

Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes.

Thomas NJ, Lynam AL, Hill AV, Weedon MN, Shields BM, Oram RA, McDonald TJ, Hattersley AT, Jones AG.

Diabetologia. 2019 Jul;62(7):1167-1172. doi: 10.1007/s00125-019-4863-8. Epub 2019 Apr 10.

9.

Persistent C-peptide is associated with reduced hypoglycaemia but not HbA1c in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice?

Marren SM, Hammersley S, McDonald TJ, Shields BM, Knight BA, Hill A, Bolt R, Tree TI, Roep BO, Hattersley AT, Jones AG, Oram RA; TIGI consortium.

Diabet Med. 2019 Sep;36(9):1092-1099. doi: 10.1111/dme.13960. Epub 2019 Jun 27.

PMID:
30955221
10.

Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010-2017.

Dennis JM, Henley WE, McGovern AP, Farmer AJ, Sattar N, Holman RR, Pearson ER, Hattersley AT, Shields BM, Jones AG; MASTERMIND consortium.

Diabetes Obes Metab. 2019 Jul;21(7):1576-1584. doi: 10.1111/dom.13687. Epub 2019 Apr 4.

11.

Nanomagnetism of Magnetoelectric Granular Thin-Film Antiferromagnets.

Appel P, Shields BJ, Kosub T, Hedrich N, Hübner R, Faßbender J, Makarov D, Maletinsky P.

Nano Lett. 2019 Mar 13;19(3):1682-1687. doi: 10.1021/acs.nanolett.8b04681. Epub 2019 Feb 12.

PMID:
30702895
12.

The NUP98-HOXD13 fusion oncogene induces thymocyte self-renewal via Lmo2/Lyl1.

Shields BJ, Slape CI, Vo N, Jackson JT, Pliego-Zamora A, Ranasinghe H, Shi W, Curtis DJ, McCormack MP.

Leukemia. 2019 Aug;33(8):1868-1880. doi: 10.1038/s41375-018-0361-0. Epub 2019 Jan 30.

PMID:
30700838
13.

Loss of E-Cadherin Inhibits CD103 Antitumor Activity and Reduces Checkpoint Blockade Responsiveness in Melanoma.

Shields BD, Koss B, Taylor EM, Storey AJ, West KL, Byrum SD, Mackintosh SG, Edmondson R, Mahmoud F, Shalin SC, Tackett AJ.

Cancer Res. 2019 Mar 15;79(6):1113-1123. doi: 10.1158/0008-5472.CAN-18-1722. Epub 2019 Jan 23.

PMID:
30674537
14.

Evaluating associations between the benefits and risks of drug therapy in type 2 diabetes: a joint modeling approach.

Dennis JM, Shields BM, Jones AG, Pearson ER, Hattersley AT, Henley WE; MASTERMIND consortium.

Clin Epidemiol. 2018 Dec 14;10:1869-1877. doi: 10.2147/CLEP.S179555. eCollection 2018.

15.

Predicting wound healing rates and survival with the use of automated serial evaluations of burn wounds.

Rittenhouse BA, Rizzo JA, Shields BA, Rowan MP, Aden JK, Salinas J, Fenrich CA, Shingleton SK, Serio-Melvin M, Burmeister DM, Cancio LC.

Burns. 2019 Feb;45(1):48-53. doi: 10.1016/j.burns.2018.10.018. Epub 2018 Nov 22.

PMID:
30473409
16.

Zinc Transporter 8 Autoantibodies (ZnT8A) and a Type 1 Diabetes Genetic Risk Score Can Exclude Individuals With Type 1 Diabetes From Inappropriate Genetic Testing for Monogenic Diabetes.

Patel KA, Weedon MN, Shields BM, Pearson ER, Hattersley AT, McDonald TJ; UNITED study team.

Diabetes Care. 2019 Feb;42(2):e16-e17. doi: 10.2337/dc18-0373. Epub 2018 Nov 8. No abstract available.

PMID:
30409810
17.

A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy.

Grubb AL, McDonald TJ, Rutters F, Donnelly LA, Hattersley AT, Oram RA, Palmer CNA, van der Heijden AA, Carr F, Elders PJM, Weedon MN, Slieker RC, 't Hart LM, Pearson ER, Shields BM, Jones AG.

Diabetes Care. 2019 Feb;42(2):208-214. doi: 10.2337/dc18-0431. Epub 2018 Oct 23.

PMID:
30352895
18.

A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin.

Shepherd MH, Shields BM, Hudson M, Pearson ER, Hyde C, Ellard S, Hattersley AT, Patel KA; UNITED study.

Diabetologia. 2018 Dec;61(12):2520-2527. doi: 10.1007/s00125-018-4728-6. Epub 2018 Sep 18.

19.

Angioinvasive fungal infections impacting the skin: Background, epidemiology, and clinical presentation.

Shields BE, Rosenbach M, Brown-Joel Z, Berger AP, Ford BA, Wanat KA.

J Am Acad Dermatol. 2019 Apr;80(4):869-880.e5. doi: 10.1016/j.jaad.2018.04.059. Epub 2018 Aug 10. Review.

PMID:
30102951
20.

Angioinvasive fungal infections impacting the skin: Diagnosis, management, and complications.

Berger AP, Ford BA, Brown-Joel Z, Shields BE, Rosenbach M, Wanat KA.

J Am Acad Dermatol. 2019 Apr;80(4):883-898.e2. doi: 10.1016/j.jaad.2018.04.058. Epub 2018 Aug 10. Review.

PMID:
30102950
21.

Dissociable Structural and Functional Hippocampal Outputs via Distinct Subiculum Cell Classes.

Cembrowski MS, Phillips MG, DiLisio SF, Shields BC, Winnubst J, Chandrashekar J, Bas E, Spruston N.

Cell. 2018 Aug 9;174(4):1036. doi: 10.1016/j.cell.2018.07.039. No abstract available.

22.

Increasing Access to High Value Care: Preventing Complications in Common Disorders.

Brin Hermans L, Shields BE, Garland CB, Aagaard-Kienitz B, Wargowski D, Kovarik C, Arkin LM.

Telemed J E Health. 2019 May;25(5):423-424. doi: 10.1089/tmj.2018.0003. Epub 2018 Aug 10.

PMID:
30096025
23.

Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic.

Clissold RL, Fulford J, Hudson M, Shields BM, McDonald TJ, Ellard S, Hattersley AT, Bingham C.

Clin Kidney J. 2018 Aug;11(4):453-458. doi: 10.1093/ckj/sfx150. Epub 2018 Jan 30.

24.

Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data.

Dennis JM, Henley WE, Weedon MN, Lonergan M, Rodgers LR, Jones AG, Hamilton WT, Sattar N, Janmohamed S, Holman RR, Pearson ER, Shields BM, Hattersley AT; MASTERMIND Consortium.

Diabetes Care. 2018 Sep;41(9):1844-1853. doi: 10.2337/dc18-0344. Epub 2018 Aug 2.

25.

Infant with an unusual pharyngeal mass.

Shields BB, Lampson EE, Sengupta AL, Watt TC, Mitchell RB.

Ear Nose Throat J. 2018 Jun;97(6):154-155. No abstract available.

PMID:
30036410
26.

Effect of perchlorate and thiocyanate exposure on thyroid function of pregnant women from South-West England: a cohort study.

Knight BA, Shields BM, He X, Pearce EN, Braverman LE, Sturley R, Vaidya B.

Thyroid Res. 2018 Jul 6;11:9. doi: 10.1186/s13044-018-0053-x. eCollection 2018.

27.

A Survey of Temperature Management Practices Among Burn Centers in North America.

Pruskowski KA, Rizzo JA, Shields BA, Chan RK, Driscoll IR, Rowan MP, Chung KK.

J Burn Care Res. 2018 Jun 13;39(4):612-617. doi: 10.1093/jbcr/irx034.

PMID:
29901801
28.

C-Peptide Decline in Type 1 Diabetes Has Two Phases: An Initial Exponential Fall and a Subsequent Stable Phase.

Shields BM, McDonald TJ, Oram R, Hill A, Hudson M, Leete P, Pearson ER, Richardson SJ, Morgan NG, Hattersley AT; TIGI Consortium.

Diabetes Care. 2018 Jul;41(7):1486-1492. doi: 10.2337/dc18-0465. Epub 2018 Jun 7.

29.

Predicting the Ability of Wounds to Heal Given Any Burn Size and Fluid Volume: An Analytical Approach.

Liu NT, Rizzo JA, Shields BA, Serio-Melvin ML, Christy RJ, Salinas J.

J Burn Care Res. 2018 Aug 17;39(5):661-669. doi: 10.1093/jbcr/iry021.

PMID:
29757400
30.

Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017.

Curtis HJ, Dennis JM, Shields BM, Walker AJ, Bacon S, Hattersley AT, Jones AG, Goldacre B.

Diabetes Obes Metab. 2018 Sep;20(9):2159-2168. doi: 10.1111/dom.13346. Epub 2018 Jun 5.

31.

Successful Treatment of Cerebral Toxoplasmosis Using Pyrimethamine Oral Solution Compounded From Inexpensive Bulk Powder.

Hodgson HA, Sim T, Gonzalez H, Aziz M, Rhee Y, Lewis PO, Jhobalia N, Shields B, Wang SK.

Open Forum Infect Dis. 2018 Apr 18;5(4):ofy055. doi: 10.1093/ofid/ofy055. eCollection 2018 Apr.

32.

Dissociable Structural and Functional Hippocampal Outputs via Distinct Subiculum Cell Classes.

Cembrowski MS, Phillips MG, DiLisio SF, Shields BC, Winnubst J, Chandrashekar J, Bas E, Spruston N.

Cell. 2018 May 17;173(5):1280-1292.e18. doi: 10.1016/j.cell.2018.03.031. Epub 2018 Apr 19. Erratum in: Cell. 2018 Aug 9;174(4):1036.

33.

Efficient Extraction of Light from a Nitrogen-Vacancy Center in a Diamond Parabolic Reflector.

Wan NH, Shields BJ, Kim D, Mouradian S, Lienhard B, Walsh M, Bakhru H, Schröder T, Englund D.

Nano Lett. 2018 May 9;18(5):2787-2793. doi: 10.1021/acs.nanolett.7b04684. Epub 2018 Apr 3.

PMID:
29601205
34.

Genetic risk scores in adult-onset type 1 diabetes - Authors' reply.

Thomas NJ, Jones SE, Weedon MN, Shields BM, Hattersley AT, Oram RA.

Lancet Diabetes Endocrinol. 2018 Mar;6(3):169. doi: 10.1016/S2213-8587(18)30046-9. No abstract available.

PMID:
29475496
35.

Fetal Genotype and Maternal Glucose Have Independent and Additive Effects on Birth Weight.

Hughes AE, Nodzenski M, Beaumont RN, Talbot O, Shields BM, Scholtens DM, Knight BA, Lowe WL Jr, Hattersley AT, Freathy RM.

Diabetes. 2018 May;67(5):1024-1029. doi: 10.2337/db17-1188. Epub 2018 Feb 20.

36.

Hhex induces promyelocyte self-renewal and cooperates with growth factor independence to cause myeloid leukemia in mice.

Jackson JT, Ng AP, Shields BJ, Haupt S, Haupt Y, McCormack MP.

Blood Adv. 2018 Feb 27;2(4):347-360. doi: 10.1182/bloodadvances.2017013243.

37.

Long-Lived Charge-Transfer States of Nickel(II) Aryl Halide Complexes Facilitate Bimolecular Photoinduced Electron Transfer.

Shields BJ, Kudisch B, Scholes GD, Doyle AG.

J Am Chem Soc. 2018 Feb 28;140(8):3035-3039. doi: 10.1021/jacs.7b13281. Epub 2018 Feb 12.

38.

Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy.

Dennis JM, Shields BM, Hill AV, Knight BA, McDonald TJ, Rodgers LR, Weedon MN, Henley WE, Sattar N, Holman RR, Pearson ER, Hattersley AT, Jones AG; MASTERMIND Consortium.

Diabetes Care. 2018 Apr;41(4):705-712. doi: 10.2337/dc17-1827. Epub 2018 Jan 31.

39.

Analysis of Histone Modifications in Acute Myeloid Leukaemia Using Chromatin Immunoprecipitation.

Shields BJ, Keniry A, Blewitt ME, McCormack MP.

Methods Mol Biol. 2018;1725:177-184. doi: 10.1007/978-1-4939-7568-6_15.

PMID:
29322418
40.

A Hairy Situation: Laser Hair Removal after Oral Reconstruction.

Shields BE, Moye MS, Bayon R, Sperry SM, Wanat KA.

Ann Otol Rhinol Laryngol. 2018 Mar;127(3):205-208. doi: 10.1177/0003489417750930. Epub 2017 Dec 31.

PMID:
29291276
41.

Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank.

Thomas NJ, Jones SE, Weedon MN, Shields BM, Oram RA, Hattersley AT.

Lancet Diabetes Endocrinol. 2018 Feb;6(2):122-129. doi: 10.1016/S2213-8587(17)30362-5. Epub 2017 Nov 30.

42.

Cohort profile for the MASTERMIND study: using the Clinical Practice Research Datalink (CPRD) to investigate stratification of response to treatment in patients with type 2 diabetes.

Rodgers LR, Weedon MN, Henley WE, Hattersley AT, Shields BM.

BMJ Open. 2017 Oct 12;7(10):e017989. doi: 10.1136/bmjopen-2017-017989.

43.

Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia.

Hope SV, Knight BA, Shields BM, Hill AV, Choudhary P, Strain WD, McDonald TJ, Jones AG.

Diabetologia. 2018 Jan;61(1):66-74. doi: 10.1007/s00125-017-4449-2. Epub 2017 Oct 5.

44.

Are we missing hypoglycaemia? Elderly patients with insulin-treated diabetes present to primary care frequently with non-specific symptoms associated with hypoglycaemia.

Hope SV, Taylor PJ, Shields BM, Hattersley AT, Hamilton W.

Prim Care Diabetes. 2018 Apr;12(2):139-146. doi: 10.1016/j.pcd.2017.08.004. Epub 2017 Sep 11.

45.

Developing a Comprehensive Cardio-Oncology Program at a Cancer Institute: The Moffitt Cancer Center Experience.

Fradley MG, Brown AC, Shields B, Viganego F, Damrongwatanasuk R, Patel AA, Hartlage G, Roper N, Jaunese J, Roy L, Ismail-Khan R.

Oncol Rev. 2017 Jul 18;11(2):340. doi: 10.4081/oncol.2017.340. eCollection 2017 Jun 14. Review.

46.

Population-Based Assessment of a Biomarker-Based Screening Pathway to Aid Diagnosis of Monogenic Diabetes in Young-Onset Patients.

Shields BM, Shepherd M, Hudson M, McDonald TJ, Colclough K, Peters J, Knight B, Hyde C, Ellard S, Pearson ER, Hattersley AT; UNITED study team.

Diabetes Care. 2017 Aug;40(8):1017-1025. doi: 10.2337/dc17-0224.

47.

Do checkpoint inhibitors rely on gut microbiota to fight cancer?

Firwana B, Avaritt N, Shields B, Ravilla R, Makhoul I, Hutchins L, Tackett AJ, Mahmoud F.

J Oncol Pharm Pract. 2018 Sep;24(6):468-472. doi: 10.1177/1078155217715903. Epub 2017 Jun 17. Review.

PMID:
28625074
48.

Hhex Regulates Hematopoietic Stem Cell Self-Renewal and Stress Hematopoiesis via Repression of Cdkn2a.

Jackson JT, Shields BJ, Shi W, Di Rago L, Metcalf D, Nicola NA, McCormack MP.

Stem Cells. 2017 Aug;35(8):1948-1957. doi: 10.1002/stem.2648. Epub 2017 Jun 19.

49.

Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack.

Mahmoud F, Shields B, Makhoul I, Avaritt N, Wong HK, Hutchins LF, Shalin S, Tackett AJ.

Cancer Biol Ther. 2017 Jul 3;18(7):451-469. doi: 10.1080/15384047.2017.1323596. Epub 2017 May 17. Review.

50.

Mild, Redox-Neutral Formylation of Aryl Chlorides through the Photocatalytic Generation of Chlorine Radicals.

Nielsen MK, Shields BJ, Liu J, Williams MJ, Zacuto MJ, Doyle AG.

Angew Chem Int Ed Engl. 2017 Jun 12;56(25):7191-7194. doi: 10.1002/anie.201702079. Epub 2017 May 23.

Supplemental Content

Loading ...
Support Center